User profiles for Urs Jacob Muehlematter

Urs Jacob Muehlematter

Radiologist, Nuclear medicine physician, University Hospital of Zurich, Switzerland
Verified email at usz.ch
Cited by 1899

Accessibility of cancer drugs in Switzerland: time from approval to pricing decision between 2009 and 2018

KN Vokinger, UJ Muehlematter - Health Policy, 2020 - Elsevier
Background Approved drugs must be included on the so-called “special list” (SL) by the
Federal Office for Public Health (FOPH) to be reimbursed by the social health insurance in …

Access to cancer precision medicines in Switzerland: A comparative analysis (USA and EU) and health policy implications

KN Vokinger, UJ Muehlematter, TJ Rosemann - Public health genomics, 2019 - karger.com
Social health insurance is mandatory in Switzerland and covers the costs of basic medical
care. In general, with regard to medicines, the costs are only reimbursed if the drug is (1) …

Impact of time-of-flight PET on lesion detection rate in 18F-Choline PET/MR for prostate cancer.

I Burger, UJ Muehlematter, H Nagel, F Barbosa… - 2017 - Soc Nuclear Med
1081 Objectives: All PET/MR systems struggle with accurate attenuation correction (AC). Dens
material such as metal or bone is inducing false values in MR based AC maps, leading to …

The quantitative performance and optimal regularization parameter beta in block sequential regularized expectation maximization reconstructions in clinical 68Ga …

E ter Voert, UJ Muehlematter, DA Pizzuto, H Nagel… - 2018 - Soc Nuclear Med
656 Objectives: Ordered subset expectation maximization (OSEM) is a fast and one of the
most applied PET reconstruction algorithms. As image noise increases with iterations the …

Immunohistochemistry on the primary tumor for PSMA-expression might predict the detection of biochemical recurrence with 68Ga-PSMA-11-PET.

…, F Daniela, J Ruschoff, M Messerli, UJ Muehlematter… - 2020 - Soc Nuclear Med
1266 Objectives: Prostate-specific membrane antigen (PSMA) targeted PET has a high
detection rate for biochemical recurrence (BCR) of prostate cancer (PCa). Nevertheless, even at …

Ga-PSMA-11 PET/MR detects local recurrence in patients after HIFU with negative mpMRI

I Burger, J Müller, B Kranzbühler, UJ Muehlematter… - 2018 - Soc Nuclear Med
1479 Introduction: With the increase of early detected prostate cancer (PCA), focal therapy
becomes an interesting alternative to radical intervention. High-intensity focused ultrasound (…

Artificial Intelligence und Machine Learning in der Medizin: eine medizinische und rechtliche Würdigung am Beispiel der Radiologie

KN Vokinger, UJ Mühlematter, AS Becker, A Boss… - Jusletter, 2017 - zora.uzh.ch
Gerade in der Radiologie wird der Einsatz von Artificial Intelligence bzw. Machine Learning
es ermöglichen, die Arbeitslast der Ärzteschaft zu reduzieren und dadurch zB mehr Zeit für …

[HTML][HTML] Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards

SM Christ, P Heesen, UJ Muehlematter, K Pohl… - Clinical and …, 2023 - Elsevier
Background and introduction Growing evidence supports a combined modality treatment
strategy for patients with oligometastatic disease. However, lack of phase III trial data and …

Texture analysis of myocardial infarction in CT: comparison with visual analysis and impact of iterative reconstruction

M Mannil, J von Spiczak, UJ Muehlematter… - European journal of …, 2019 - Elsevier
… Author links open overlay panel Manoj Mannil a , Jochen von Spiczak a , Urs J. Muehlematter
a , Arjun Thanabalasingam a , Dagmar I. Keller c , Robert Manka a b d , Hatem Alkadhi a …

Disentangling human error from ground truth in segmentation of medical images

…, R Tanno, MC Xu, C Jin, J Jacob… - Advances in …, 2020 - proceedings.neurips.cc
Recent years have seen increasing use of supervised learning methods for segmentation
tasks. However, the predictive performance of these algorithms depends on the quality of …